| A Novel d‐Peptide Identified by Mirror‐Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy X Zhou, C Zuo, W Li, W Shi, X Zhou, H Wang, S Chen, J Du, G Chen, ... Angewandte Chemie International Edition 59 (35), 15114-15118, 2020 | 100 | 2020 |
| Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway Y Sun, Y Qian, C Chen, H Wang, X Zhou, W Zhai, L Qiu, X Zhou, H Ning, ... Journal of Experimental & Clinical Cancer Research 41 (1), 145, 2022 | 28 | 2022 |
| Hollow polydopamine spheres with removable manganese oxide nanoparticle caps for tumor microenvironment-responsive drug delivery Y Miao, X Zhou, J Bai, W Zhao, X Zhao Chemical Engineering Journal 430, 133089, 2022 | 27 | 2022 |
| Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR X Zhou, J Du, H Wang, C Chen, L Jiao, X Cheng, X Zhou, S Chen, S Gou, ... Cell Communication and Signaling 18, 1-14, 2020 | 22 | 2020 |
| Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming L Qiu, Q Yang, W Zhao, Y Xing, P Li, X Zhou, H Ning, R Shi, S Gou, ... Cell death & disease 13 (5), 501, 2022 | 15 | 2022 |
| Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells S Gou, L Qiu, Q Yang, P Li, X Zhou, Y Sun, X Zhou, W Zhao, W Zhai, G Li, ... Toxicology and Applied Pharmacology 420, 115523, 2021 | 12 | 2021 |
| Computer-aided design of PVR mutants with enhanced binding affinity to TIGIT X Zhou, J Du, X Zhou, X Niu, W Li, C Chen, S Lv, A Wu, S Gou, Y Sun, ... Cell Communication and Signaling 19, 1-13, 2021 | 5 | 2021 |
| Identification of a novel small-molecule inhibitor targeting TIM-3 for cancer immunotherapy M Wu, A Wu, X Zhang, Y Li, B Li, S Jin, Q Dong, X Niu, L Zhang, X Zhou, ... Biochemical Pharmacology 212, 115583, 2023 | 3 | 2023 |
| Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy X Niu, M Wu, G Li, X Zhou, W Cao, W Zhai, A Wu, X Zhou, S Jin, G Chen, ... Acta Pharmaceutica Sinica B 13 (11), 4511-4522, 2023 | 2 | 2023 |
| Identification of natural product 3, 5-diiodotyrosine as APOBEC3B inhibitor to prevent somatic mutation accumulation and cancer progression C Chen, X Sui, H Ning, Y Sun, J Du, X Chen, X Zhou, G Chen, W Shen, ... Journal for Immunotherapy of Cancer 10 (11), 2022 | 2 | 2022 |
| Dysfunction of novel energy sensor NFE2L1 leads to uncontrollable AMPK signal and glucose metabolism reprogramming Y Qiufang, Z Wenshan, L Peng, Z Xiaowen, N Haoming, S Ranran, ... bioRxiv, 2021.09. 07.459348, 2021 | 2 | 2021 |
| Function expansion of antitumor transcriptional activator NFE2L1 by the original discovery of its non-transcription factor activity Q Lu, Y Qiufang, L Peng, Z Xiaowen, Y Yonghui, Z Xiuman, G Shanshan, ... bioRxiv, 2020.10. 08.330597, 2020 | 1 | 2020 |
| Repurposing hypothyroidism drug liothyronine for cancer immunotherapy X Zhou, J Du, H Wang, C Chen, L Jiao, X Cheng, X Zhou, S Chen, S Gou, ... | | 2020 |
